Cargando…
Pemigatinib treatment for intrahepatic cholangiocarcinoma with FGFR2 fusion detected by a liquid comprehensive genomic profiling test
The liquid CGP was useful for detecting FGFR2 fusion and the patient experienced typical side effects (nail disorders, hyperphosphatemia, and taste disorders) of pemigatinib that required treatment.
| Autores principales: | , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10320371/ https://www.ncbi.nlm.nih.gov/pubmed/37415592 http://dx.doi.org/10.1002/ccr3.7664 |
| _version_ | 1785068438705668096 |
|---|---|
| author | Ishido, Shun Tamaki, Nobuharu Inada, Kento Itakura, Jun Takahashi, Yuka Uchihara, Naoki Suzuki, Keito Tanaka, Yuki Miyamoto, Haruka Yamada, Michiko Matsumoto, Hiroaki Nobusawa, Tsubasa Keitoku, Taisei Takaura, Kenta Tanaka, Shohei Maeyashiki, Chiaki Yasui, Yutaka Tsuchiya, Kaoru Nakanishi, Hiroyuki Kurosaki, Masayuki Izumi, Namiki |
| author_facet | Ishido, Shun Tamaki, Nobuharu Inada, Kento Itakura, Jun Takahashi, Yuka Uchihara, Naoki Suzuki, Keito Tanaka, Yuki Miyamoto, Haruka Yamada, Michiko Matsumoto, Hiroaki Nobusawa, Tsubasa Keitoku, Taisei Takaura, Kenta Tanaka, Shohei Maeyashiki, Chiaki Yasui, Yutaka Tsuchiya, Kaoru Nakanishi, Hiroyuki Kurosaki, Masayuki Izumi, Namiki |
| author_sort | Ishido, Shun |
| collection | PubMed |
| description | The liquid CGP was useful for detecting FGFR2 fusion and the patient experienced typical side effects (nail disorders, hyperphosphatemia, and taste disorders) of pemigatinib that required treatment. |
| format | Online Article Text |
| id | pubmed-10320371 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-103203712023-07-06 Pemigatinib treatment for intrahepatic cholangiocarcinoma with FGFR2 fusion detected by a liquid comprehensive genomic profiling test Ishido, Shun Tamaki, Nobuharu Inada, Kento Itakura, Jun Takahashi, Yuka Uchihara, Naoki Suzuki, Keito Tanaka, Yuki Miyamoto, Haruka Yamada, Michiko Matsumoto, Hiroaki Nobusawa, Tsubasa Keitoku, Taisei Takaura, Kenta Tanaka, Shohei Maeyashiki, Chiaki Yasui, Yutaka Tsuchiya, Kaoru Nakanishi, Hiroyuki Kurosaki, Masayuki Izumi, Namiki Clin Case Rep Case Report The liquid CGP was useful for detecting FGFR2 fusion and the patient experienced typical side effects (nail disorders, hyperphosphatemia, and taste disorders) of pemigatinib that required treatment. John Wiley and Sons Inc. 2023-07-05 /pmc/articles/PMC10320371/ /pubmed/37415592 http://dx.doi.org/10.1002/ccr3.7664 Text en © 2023 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Case Report Ishido, Shun Tamaki, Nobuharu Inada, Kento Itakura, Jun Takahashi, Yuka Uchihara, Naoki Suzuki, Keito Tanaka, Yuki Miyamoto, Haruka Yamada, Michiko Matsumoto, Hiroaki Nobusawa, Tsubasa Keitoku, Taisei Takaura, Kenta Tanaka, Shohei Maeyashiki, Chiaki Yasui, Yutaka Tsuchiya, Kaoru Nakanishi, Hiroyuki Kurosaki, Masayuki Izumi, Namiki Pemigatinib treatment for intrahepatic cholangiocarcinoma with FGFR2 fusion detected by a liquid comprehensive genomic profiling test |
| title | Pemigatinib treatment for intrahepatic cholangiocarcinoma with FGFR2 fusion detected by a liquid comprehensive genomic profiling test |
| title_full | Pemigatinib treatment for intrahepatic cholangiocarcinoma with FGFR2 fusion detected by a liquid comprehensive genomic profiling test |
| title_fullStr | Pemigatinib treatment for intrahepatic cholangiocarcinoma with FGFR2 fusion detected by a liquid comprehensive genomic profiling test |
| title_full_unstemmed | Pemigatinib treatment for intrahepatic cholangiocarcinoma with FGFR2 fusion detected by a liquid comprehensive genomic profiling test |
| title_short | Pemigatinib treatment for intrahepatic cholangiocarcinoma with FGFR2 fusion detected by a liquid comprehensive genomic profiling test |
| title_sort | pemigatinib treatment for intrahepatic cholangiocarcinoma with fgfr2 fusion detected by a liquid comprehensive genomic profiling test |
| topic | Case Report |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10320371/ https://www.ncbi.nlm.nih.gov/pubmed/37415592 http://dx.doi.org/10.1002/ccr3.7664 |
| work_keys_str_mv | AT ishidoshun pemigatinibtreatmentforintrahepaticcholangiocarcinomawithfgfr2fusiondetectedbyaliquidcomprehensivegenomicprofilingtest AT tamakinobuharu pemigatinibtreatmentforintrahepaticcholangiocarcinomawithfgfr2fusiondetectedbyaliquidcomprehensivegenomicprofilingtest AT inadakento pemigatinibtreatmentforintrahepaticcholangiocarcinomawithfgfr2fusiondetectedbyaliquidcomprehensivegenomicprofilingtest AT itakurajun pemigatinibtreatmentforintrahepaticcholangiocarcinomawithfgfr2fusiondetectedbyaliquidcomprehensivegenomicprofilingtest AT takahashiyuka pemigatinibtreatmentforintrahepaticcholangiocarcinomawithfgfr2fusiondetectedbyaliquidcomprehensivegenomicprofilingtest AT uchiharanaoki pemigatinibtreatmentforintrahepaticcholangiocarcinomawithfgfr2fusiondetectedbyaliquidcomprehensivegenomicprofilingtest AT suzukikeito pemigatinibtreatmentforintrahepaticcholangiocarcinomawithfgfr2fusiondetectedbyaliquidcomprehensivegenomicprofilingtest AT tanakayuki pemigatinibtreatmentforintrahepaticcholangiocarcinomawithfgfr2fusiondetectedbyaliquidcomprehensivegenomicprofilingtest AT miyamotoharuka pemigatinibtreatmentforintrahepaticcholangiocarcinomawithfgfr2fusiondetectedbyaliquidcomprehensivegenomicprofilingtest AT yamadamichiko pemigatinibtreatmentforintrahepaticcholangiocarcinomawithfgfr2fusiondetectedbyaliquidcomprehensivegenomicprofilingtest AT matsumotohiroaki pemigatinibtreatmentforintrahepaticcholangiocarcinomawithfgfr2fusiondetectedbyaliquidcomprehensivegenomicprofilingtest AT nobusawatsubasa pemigatinibtreatmentforintrahepaticcholangiocarcinomawithfgfr2fusiondetectedbyaliquidcomprehensivegenomicprofilingtest AT keitokutaisei pemigatinibtreatmentforintrahepaticcholangiocarcinomawithfgfr2fusiondetectedbyaliquidcomprehensivegenomicprofilingtest AT takaurakenta pemigatinibtreatmentforintrahepaticcholangiocarcinomawithfgfr2fusiondetectedbyaliquidcomprehensivegenomicprofilingtest AT tanakashohei pemigatinibtreatmentforintrahepaticcholangiocarcinomawithfgfr2fusiondetectedbyaliquidcomprehensivegenomicprofilingtest AT maeyashikichiaki pemigatinibtreatmentforintrahepaticcholangiocarcinomawithfgfr2fusiondetectedbyaliquidcomprehensivegenomicprofilingtest AT yasuiyutaka pemigatinibtreatmentforintrahepaticcholangiocarcinomawithfgfr2fusiondetectedbyaliquidcomprehensivegenomicprofilingtest AT tsuchiyakaoru pemigatinibtreatmentforintrahepaticcholangiocarcinomawithfgfr2fusiondetectedbyaliquidcomprehensivegenomicprofilingtest AT nakanishihiroyuki pemigatinibtreatmentforintrahepaticcholangiocarcinomawithfgfr2fusiondetectedbyaliquidcomprehensivegenomicprofilingtest AT kurosakimasayuki pemigatinibtreatmentforintrahepaticcholangiocarcinomawithfgfr2fusiondetectedbyaliquidcomprehensivegenomicprofilingtest AT izuminamiki pemigatinibtreatmentforintrahepaticcholangiocarcinomawithfgfr2fusiondetectedbyaliquidcomprehensivegenomicprofilingtest |